Semnur Pharmaceuticals, Inc. SEC filings SMNR
Semnur Pharmaceuticals, Inc. has 221 filings in SEC EDGAR's recent list, going back to Mar 1, 2022. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 26, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 15, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 14, 2025 | — |
| 3 | Initial insider ownership | Sep 26, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 25, 2025 | Sep 23, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 26, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 16, 2024 | — |
| 4 | Insider transaction | Sep 16, 2024 | Aug 30, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Aug 30, 2024 |
| SC 13D | Ownership over 5% (active) | Sep 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 7, 2023 | — |
| SC 13G | Ownership over 5% (passive) | May 16, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Oct 20, 2022 | — |
| 4 | Insider transaction | May 24, 2022 | May 21, 2022 |
| 4 | Insider transaction | May 24, 2022 | May 21, 2022 |
| 4 | Insider transaction | Apr 13, 2022 | Apr 11, 2022 |
| 4 | Insider transaction | Apr 13, 2022 | Apr 11, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
| 3 | Initial insider ownership | Apr 6, 2022 | Apr 6, 2022 |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SMNR (OTC), SMNRW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1913577
- Former names
- Denali Capital Acquisition Corp. (until Sep 23, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.